CN102727834B - Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof - Google Patents
Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof Download PDFInfo
- Publication number
- CN102727834B CN102727834B CN 201210248282 CN201210248282A CN102727834B CN 102727834 B CN102727834 B CN 102727834B CN 201210248282 CN201210248282 CN 201210248282 CN 201210248282 A CN201210248282 A CN 201210248282A CN 102727834 B CN102727834 B CN 102727834B
- Authority
- CN
- China
- Prior art keywords
- parts
- add
- chinese medicine
- medicine composition
- migraine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 208000019695 Migraine disease Diseases 0.000 title claims abstract description 26
- 206010027599 migraine Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 241000238413 Octopus Species 0.000 claims abstract description 15
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 14
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 14
- 241000218176 Corydalis Species 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 238000003756 stirring Methods 0.000 claims description 32
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000407170 Curcuma Species 0.000 claims description 13
- 239000000725 suspension Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- 238000005325 percolation Methods 0.000 claims description 9
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 8
- 239000005995 Aluminium silicate Substances 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 235000012211 aluminium silicate Nutrition 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 8
- 239000008273 gelatin Substances 0.000 claims description 8
- 229920000159 gelatin Polymers 0.000 claims description 8
- 235000019322 gelatine Nutrition 0.000 claims description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 8
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 7
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 7
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 7
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 6
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 6
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 6
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000009736 wetting Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 4
- 241001647939 Ardisia crispa Species 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004494 ethyl ester group Chemical group 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims 1
- 230000006837 decompression Effects 0.000 claims 1
- 239000012567 medical material Substances 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000002674 ointment Substances 0.000 abstract description 3
- 244000164439 Curcuma angustifolia Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 9
- 231100000869 headache Toxicity 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 241000143437 Aciculosporium take Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015015 neurological dysfunction Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002089 prostaglandin antagonist Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000009284 zhennaoning Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
本发明提供一种中药组合物,通过活血化瘀、行气止痛,达到治疗偏头痛之目的,为了达到这个目地,采用如下技术方案:它所含的活性成分由下列重量份原料药配比制备而成:莪术10-30份、八爪金龙5-15份、追风伞10-20份、延胡索5-15份,并采用了相应的制备方法制备得到巴布膏剂,该中药组合物具有治疗偏头痛的功效。The invention provides a traditional Chinese medicine composition, which achieves the purpose of treating migraine by promoting blood circulation, removing blood stasis, promoting qi and relieving pain. In order to achieve this purpose, the following technical scheme is adopted: the active ingredients contained in it are prepared by the following ratio of raw materials by weight: Formation: 10-30 parts of Curcuma, 5-15 parts of Octopus Golden Dragon, 10-20 parts of Zhaifeng Umbrella, 5-15 parts of Corydalis Corydalis, and the corresponding preparation method is used to prepare Babu ointment. The traditional Chinese medicine composition has therapeutic Efficacy for migraines.
Description
技术领域 technical field
本发明涉及中药制剂技术领域,具体涉及一种治疗偏头痛的中药组合物和制法及应用。The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine composition for treating migraine, a preparation method and application thereof.
背景技术 Background technique
偏头疼是反复发作的一种搏动性头疼,属众多头疼类型中的“大户”。它发作前常有闪光、视物模糊、肢体麻木等先兆,约数分钟至1小时左右出现一侧头部一跳一跳的疼痛,并逐渐加剧,直到出现恶心、呕吐后,感觉才会有所好转在安静、黑暗环境内或睡眠后头疼缓解。在头痛发生前或发作时可伴有神经、精神功能障碍。迄今为止,药物治疗还是控制该病的最好方法,西医以血管收缩剂、激素、前列腺素抑制剂等,但这些药物都有不同程度的毒副作用。中药制剂如芎菊上清丸、镇脑宁、延胡止痛片、复方羊角颗粒、川芍茶调袋泡剂、太极通天液、正天丸等品种,均属口服药而起效慢。目前市场急需一种治疗偏头痛的外用药。Migraine is a kind of throbbing headache that recurs, and it belongs to the "big family" among many types of headaches. Before the onset, there are often auras such as flashes of light, blurred vision, and numbness of the limbs. From a few minutes to an hour, there will be throbbing pain on one side of the head, which will gradually intensify until nausea and vomiting occur. The improvement is headache relief in a quiet, dark environment or after sleep. It may be accompanied by neurological and mental dysfunction before or during the onset of headache. So far, drug treatment is still the best way to control the disease. Western medicine uses vasoconstrictors, hormones, prostaglandin inhibitors, etc., but these drugs have different degrees of toxic and side effects. Traditional Chinese medicine preparations such as Xiongju Shangqing Pills, Zhennaoning, Yanhu Zhitong Tablets, Compound Yangjiao Granules, Chuan Shao Tea Tiao Bubbles, Taiji Tongtian Liquid, and Zhengtian Pills are all oral medicines with slow onset of action. A kind of external medicine for the treatment of migraine is urgently needed in the market at present.
发明内容 Contents of the invention
发明目的:为了解决上述问题,本发明的目的在于提供一种治疗偏头痛的中药制剂。Purpose of the invention: in order to solve the above problems, the purpose of the present invention is to provide a kind of Chinese medicine preparation for the treatment of migraine.
本发明的另一个目的在于提供一种治疗偏头痛的中药制剂制备方法和应用。Another object of the present invention is to provide a preparation method and application of a traditional Chinese medicine preparation for treating migraine.
技术方案:本发明的目的是通过如下的方案实现的:Technical scheme: the purpose of the present invention is achieved by the following scheme:
一种治疗偏头痛的中药组合物,它所含的活性成分由下列重量份原料药配比提取制备而成:莪术10-30份、八爪金龙5-15份、追风伞10-20份、延胡索5-15份。A traditional Chinese medicine composition for treating migraine, the active ingredient contained in it is prepared by extracting and proportioning the following raw materials by weight: 10-30 parts of curcuma, 5-15 parts of octopus, and 10-20 parts of chasing wind umbrella , Corydalis 5-15 copies.
上述治疗偏头痛的中药组合物,它所含的活性成分由下列重量份原料药配比提取制备而成:莪术20份、八爪金龙10份、追风伞15份、延胡索10份。The above-mentioned traditional Chinese medicine composition for treating migraine, the active ingredient contained in it is prepared by extracting the following raw materials by weight: 20 parts of curcuma, 10 parts of octopus, 15 parts of chasing wind umbrella, and 10 parts of corydalis.
上述治疗偏头痛的中药组合物,所述原料药经提取后添加基质制成巴布膏。In the above-mentioned traditional Chinese medicine composition for treating migraine, the crude drug is extracted and then added with a matrix to make a cataplasm plaster.
上述治疗偏头痛的中药组合物,所述基质为聚丙烯酸钠3-6份、聚乙烯吡咯烷酮1-3份、聚乙烯醇1-2份、明胶6-10份、羧甲基纤维素钠2-3份、甘油2-3份、白陶土3-5份、碳酸钙2-4份、氮酮2-4份、丙二醇2-4份、水6-10份及尼泊金乙酯0.02-0.04份。The above-mentioned traditional Chinese medicine composition for treating migraine, the base is 3-6 parts of sodium polyacrylate, 1-3 parts of polyvinylpyrrolidone, 1-2 parts of polyvinyl alcohol, 6-10 parts of gelatin, 2 parts of carboxymethylcellulose sodium -3 parts, glycerin 2-3 parts, kaolin 3-5 parts, calcium carbonate 2-4 parts, azone 2-4 parts, propylene glycol 2-4 parts, water 6-10 parts and ethylparaben 0.02- 0.04 parts.
上述治疗偏头痛的中药组合物的方法,制备步骤为:The method for the above-mentioned Chinese medicine composition for the treatment of migraine, the preparation steps are:
a.取莪术、八爪金龙、追风伞、延胡索药材合并,粉碎,用乙醇作溶剂,湿润5-20小时后进行渗漉,收集渗漉液,减压回收乙醇并浓缩至50℃时相对密度为1.28-1.32的稠膏;a. Combine curcuma, octopus, chasing wind umbrella, and corydalis, crush them, use ethanol as solvent, and percolate after 5-20 hours of wetting, collect the percolation liquid, recover ethanol under reduced pressure and concentrate it to 50°C. thick paste with a density of 1.28-1.32;
b.取聚丙烯酸钠、白陶土、碳酸钙加入甘油搅拌均匀,得混悬液I;b. Take sodium polyacrylate, kaolin, calcium carbonate and add glycerin and stir evenly to obtain suspension I;
c.取羧甲基纤维素钠加水,加热,时时搅拌至呈均匀,缓缓加入聚乙烯吡咯烷酮、聚乙烯醇,边加边搅拌,直至均匀,得混合物II;c. Take sodium carboxymethyl cellulose and add water, heat, stir from time to time until uniform, slowly add polyvinylpyrrolidone and polyvinyl alcohol, and stir while adding until uniform, to obtain mixture II;
d.将明胶加水,加热,搅拌至呈均匀半透明状,与混合物II合并,加入上述步骤a中得到的稠膏,搅拌均匀,再依次加入混悬液I、氮酮、丙二醇、尼泊金乙酯,搅拌均匀,趁热经涂布机涂布,切割,包装。d. Add water to the gelatin, heat, stir until it becomes uniform and translucent, combine with the mixture II, add the thick paste obtained in the above step a, stir evenly, then add the suspension I, azone, propylene glycol, and paraben in sequence Ethyl ester, stirred evenly, coated by a coating machine while hot, cut and packaged.
上述治疗偏头痛的中药组合物的制备方法,步骤a中乙醇浓度为50%,渗漉时加入量为药材重量的5倍量,减压回收乙醇并浓缩至50℃时相对密度为1.3的稠膏。In the preparation method of the above-mentioned traditional Chinese medicine composition for treating migraine, the concentration of ethanol in step a is 50%, the amount added during percolation is 5 times the weight of the medicinal material, and the ethanol is recovered under reduced pressure and concentrated to 50 DEG C with a relative density of 1.3. paste.
通过临床实验研究发现,本发明的中药组合物具有很好的治疗偏头痛作用。因此,本发明还提供了上述药物组合物的用途,即上述治疗偏头痛的中药组合物在制备治疗偏头痛药物中的应用。It is found through clinical experiment research that the traditional Chinese medicine composition of the present invention has a good effect on treating migraine. Therefore, the present invention also provides the use of the above-mentioned pharmaceutical composition, that is, the application of the above-mentioned traditional Chinese medicine composition for treating migraine in the preparation of medicine for treating migraine.
有益效果:Beneficial effect:
1、从中医理论看,本方中莪术破血行气,消积止痛,八爪金龙化瘀止血,活血定痛,莪术和八爪金龙共为君药,活血化瘀,追风伞祛风通络,活血止痛,延胡索活血、行气、止痛,追风伞和延胡索共为臣药,行气止痛,诸药相合,共奏活血化瘀、行气止痛作用,用于治疗偏头痛。2、本发明处方设计合理,配伍严谨。3、本发明组成为中药材,无毒副作用,价格便宜。1. From the perspective of traditional Chinese medicine theory, in this prescription, Curcuma breaks blood and promotes qi, eliminates stagnation and relieves pain, and Octopus Golden Dragon removes blood stasis to stop bleeding, promotes blood circulation and relieves pain. Both Curcuma and Octopus Golden Dragon are the monarch drug, promoting blood circulation and removing blood stasis, chasing wind umbrella and dispelling wind. Collaterals, promoting blood circulation and relieving pain, Corydalis activating blood circulation, promoting qi, and relieving pain, Zhuifeng Umbrella and Corydalis Corydalis are a total of ministerial medicines, promoting qi and relieving pain, all medicines are combined, and play the effects of promoting blood circulation and removing blood stasis, promoting qi and relieving pain, and are used to treat migraine. 2. The prescription design of the present invention is reasonable and the compatibility is strict. 3. The composition of the present invention is Chinese herbal medicine, has no toxic and side effects, and is cheap.
具体实施方式 Detailed ways
以下通过实施例形式,对本发明的上述内容再作进一步的详细说明,但不应将此理解为本发明上述主题的范围仅限于以下的实例,凡基于本发明上述内容所实现的技术均属于本发明的范围。Below by embodiment form, above-mentioned content of the present invention is described in further detail again, but this should not be interpreted as the scope of the above-mentioned theme of the present invention being limited to following examples, all technologies realized based on the above-mentioned content of the present invention all belong to this invention the scope of the invention.
1、结合具体实施方式,对本发明进一步说明如下:1, in conjunction with specific embodiment, the present invention is further described as follows:
按下表中所列重量配比称取本发明所需原料药,单位:份The weight ratio listed in the table below takes the required bulk drug of the present invention, unit: part
按下表中所列重量配比称取本发明所需基质原料,单位:份The weight ratio listed in the table below takes by weighing the required substrate raw materials of the present invention, unit: part
本发明中原料药中追风伞为报春花科排草属植物伞叶排草LysimachiatrientaloidesHemsl的全草,多年生草本,八爪金龙为为紫金牛科紫金牛属植物百两金Ardisia crispa(Thunb.)DC.,以根及叶入药。夏、秋采集。,其余均选用中国药典品种。The chasing wind umbrella in the raw material medicine of the present invention is the whole herb of Lysimachiatrientaloides Hemsl, a perennial herb of the genus Lysimachiatrientaloides Hemsl of the genus Primulaceae, and Ardisia crispa (Thunb.) DC., the roots and leaves are used as medicine. Summer and autumn collection. , and the rest are selected from Chinese Pharmacopoeia varieties.
2、制备实施例2, preparation embodiment
以上表中原料配比为例,包括以下步骤:The ratio of raw materials in the above table is an example, including the following steps:
实施例1:Example 1:
a.取莪术10g、八爪金龙15g、追风伞10g、延胡索15g药材合并,粉碎,用50%乙醇作溶剂,湿润5小时后进行渗漉,加5倍药材重量的50%乙醇渗漉,收集渗漉液,减压回收乙醇并浓缩至50℃时相对密度为1.28的稠膏;a. Take 10g of Curcuma, 15g of Octopus, 10g of Zhaifeng Umbrella, and 15g of Corydalis Corydalis and combine them, crush them, use 50% ethanol as solvent, and percolate after wetting for 5 hours, add 50% ethanol of 5 times the weight of the medicinal materials for percolation, Collect the percolate, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.28 at 50°C;
b.取聚丙烯酸钠3g、白陶土3g、碳酸钙4g加入甘油3g搅拌均匀,得混悬液I;b. Take 3g of sodium polyacrylate, 3g of kaolin, 4g of calcium carbonate, add 3g of glycerin and stir evenly to obtain suspension I;
c.取羧甲基纤维素钠2g加水3g,加热,时时搅拌至呈均匀,缓缓加入聚乙烯吡咯烷酮3g、聚乙烯醇1g,边加边搅拌,直至均匀,得混合物II;c. Take 2 g of sodium carboxymethyl cellulose and add 3 g of water, heat, stir from time to time until uniform, slowly add 3 g of polyvinylpyrrolidone and 1 g of polyvinyl alcohol, and stir while adding until uniform, to obtain mixture II;
d.将明胶10g加水3g,加热,搅拌至呈均匀半透明状,与混合物II合并,加入上述步骤a中得到的稠膏,搅拌均匀,再依次加入混悬液I、氮酮2g、丙二醇4g、尼泊金乙酯0.04g,搅拌均匀,趁热经涂布机涂布,切割,包装。d. Add 10g of gelatin to 3g of water, heat, stir until uniform translucency, combine with mixture II, add the thick paste obtained in the above step a, stir evenly, then add suspension I, azone 2g, propylene glycol 4g in turn 1. Ethylparaben 0.04g, stir evenly, apply by coating machine while hot, cut and pack.
实施例2:Example 2:
a.取莪术20g、八爪金龙10g、追风伞15g、延胡索10g药材合并,粉碎,用50%乙醇作溶剂,湿润15小时后进行渗漉,加5倍药材重量的50%乙醇渗漉,收集渗漉液,减压回收乙醇并浓缩至50℃时相对密度为1.30的稠膏;a. Take 20g of Curcuma, 10g of Octopus, 15g of Chasing Wind Umbrella, and 10g of Corydalis Corydalis and combine them, crush them, use 50% ethanol as a solvent, and percolate after 15 hours of wetting, add 50% ethanol of 5 times the weight of the medicinal materials for percolation, Collect the percolate, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30 at 50°C;
b.取聚丙烯酸钠5g、白陶土4g、碳酸钙3g加入甘油2.5g搅拌均匀,得混悬液I;b. Take 5g of sodium polyacrylate, 4g of kaolin, 3g of calcium carbonate, add 2.5g of glycerin and stir evenly to obtain suspension I;
c.取羧甲基纤维素钠2.5g加水4g,加热,时时搅拌至呈均匀,缓缓加入聚乙烯吡咯烷酮2g、聚乙烯醇1.5g,边加边搅拌,直至均匀,得混合物II;c. Take 2.5 g of sodium carboxymethyl cellulose and add 4 g of water, heat, stir from time to time until uniform, slowly add 2 g of polyvinylpyrrolidone and 1.5 g of polyvinyl alcohol, and stir while adding until uniform, to obtain mixture II;
d.将明胶8g加水4g,加热,搅拌至呈均匀半透明状,与混合物II合并,加入上述步骤a中得到的稠膏,搅拌均匀,再依次加入混悬液I、氮酮3g、丙二醇3g、尼泊金乙酯0.03g,搅拌均匀,趁热经涂布机涂布,切割,包装。d. Add 8g of gelatin to 4g of water, heat, stir until uniform translucency, combine with mixture II, add the thick paste obtained in the above step a, stir evenly, then add suspension I, azone 3g, propylene glycol 3g in turn 1. Ethylparaben 0.03g, stir evenly, apply by coating machine while hot, cut and pack.
实施例3:Example 3:
a.取莪术30g、八爪金龙5g、追风伞20g、延胡索5g药材合并,粉碎,用50%乙醇作溶剂,湿润15小时后进行渗漉,加5倍药材重量的50%乙醇渗漉,收集渗漉液,减压回收乙醇并浓缩至50℃时相对密度为1.30的稠膏;a. Take 30g of Curcuma, 5g of Octopus, 20g of Chasing Wind Umbrella, and 5g of Corydalis Corydalis and combine them, crush them, use 50% ethanol as a solvent, and percolate after 15 hours of wetting, add 50% ethanol of 5 times the weight of the medicinal materials for percolation, Collect the percolate, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30 at 50°C;
b.取聚丙烯酸钠6g、白陶土5g、碳酸钙2g加入甘油2g搅拌均匀,得混悬液I;b. Take 6 g of sodium polyacrylate, 5 g of kaolin, 2 g of calcium carbonate, add 2 g of glycerin and stir evenly to obtain suspension I;
c.取羧甲基纤维素钠3g加水5g,加热,时时搅拌至呈均匀,缓缓加入聚乙烯吡咯烷酮1g、聚乙烯醇2g,边加边搅拌,直至均匀,得混合物II;c. Take 3 g of sodium carboxymethyl cellulose and add 5 g of water, heat, stir from time to time until uniform, slowly add 1 g of polyvinylpyrrolidone and 2 g of polyvinyl alcohol, and stir while adding until uniform, to obtain mixture II;
d.将明胶6g加水5g,加热,搅拌至呈均匀半透明状,与混合物II合并,加入上述步骤a中得到的稠膏,搅拌均匀,再依次加入混悬液I、氮酮4g、丙二醇2g、尼泊金乙酯0.02g,搅拌均匀,趁热经涂布机涂布,切割,包装。d. Add 6 g of gelatin to 5 g of water, heat, stir until it becomes uniform and translucent, combine with mixture II, add the thick paste obtained in the above step a, stir evenly, then add suspension I, azone 4 g, and propylene glycol 2 g in sequence 1. Ethylparaben 0.02g, stir evenly, apply by coating machine while hot, cut and pack.
3.临床观察及典型病例:本发明中药组合物治疗偏头痛患者的临床疗效观察实验3. Clinical Observation and Typical Cases: Clinical Curative Effect Observation Experiment of Chinese Medicine Composition of the Present Invention in Treating Migraine Patients
一、实验对象的一般资料:采用本发明中药组合物共治疗30例,其中男性18例,女性12例,年龄最大者52岁,年龄最小者35岁,平均年龄在44.5岁,病程在5个月-10年之间,平均为2年半,每月发作次数在2-4次,每次发作持续时间1-4天,平均发作次数为3次/月,持续时间为3天。所有偏头痛患者皆为门诊患者,全部病例均经颅脑CT检查未见异常,并根据病史、体格检查及相关检查排除其他病因所致头痛,无高血压、癫痫等疾病,所有患者就诊前1个月未服用其他治疗头痛的药物。One, the general data of experimental object: adopt Chinese medicine composition of the present invention to treat altogether 30 cases, wherein 18 cases are male, 12 cases are female, the oldest person is 52 years old, the youngest person is 35 years old, the average age is 44.5 years old, and the course of disease is 5 months old. Between months and 10 years, with an average of 2 and a half years, the number of episodes per month is 2-4 times, and the duration of each episode is 1-4 days. The average number of episodes is 3 times/month, and the duration is 3 days. All patients with migraine were outpatients. No abnormalities were found in brain CT examinations in all cases, and headaches caused by other causes were excluded according to medical history, physical examination and related examinations. There were no hypertension, epilepsy and other diseases. Month did not take other medicines for the treatment of headache.
二、治疗方法:用法用量:采用本发明实施例2所制备的巴布膏,步骤为a.取莪术20g、八爪金龙10g、追风伞15g、延胡索10g药材合并,粉碎,用50%乙醇作溶剂,湿润15小时后进行渗漉,加5倍药材重量的50%乙醇渗漉,收集渗漉液,减压回收乙醇并浓缩至50℃时相对密度为1.30的稠膏;b.取聚丙烯酸钠5g、白陶土4g、碳酸钙3g加入甘油2.5g搅拌均匀,得混悬液I;c.取羧甲基纤维素钠2.5g加水4g,加热,时时搅拌至呈均匀,缓缓加入聚乙烯吡咯烷酮2g、聚乙烯醇1.5g,边加边搅拌,直至均匀,得混合物II;d.将明胶8g加水4g,加热,搅拌至呈均匀半透明状,与混合物II合并,加入上述步骤a中得到的稠膏,搅拌均匀,再依次加入混悬液I、氮酮3g、丙二醇3g、尼泊金乙酯0.03g,搅拌均匀,趁热经涂布机涂布,切割,包装,得10片巴布膏剂,其用法与用量为每次1贴,每日3次,太阳穴处敷贴,一个月为一疗程,共治疗3个疗程。2. Therapeutic method: usage and dosage: adopt the babu ointment prepared by the embodiment of the present invention 2, the steps are a. Get 20g of curcuma, 10g of octopus, 15g of chasing wind umbrella, and 10g of Corydalis 10g medicinal materials, pulverize, and use 50% ethanol As a solvent, percolate after wetting for 15 hours, add 50% ethanol of 5 times the weight of medicinal materials for percolation, collect the percolation liquid, recycle ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30 when it is concentrated to 50°C; b. Add 5g of sodium acrylate, 4g of kaolin, 3g of calcium carbonate, add 2.5g of glycerin and stir evenly to obtain suspension I; c. Take 2.5g of sodium carboxymethyl cellulose and add 4g of water, heat, stir from time to time until uniform, slowly add poly Add 2g of vinylpyrrolidone and 1.5g of polyvinyl alcohol, stir until uniform, and obtain mixture II; d. add 8g of gelatin to 4g of water, heat, stir until uniform and translucent, combine with mixture II, and add to the above step a The obtained thick paste was stirred evenly, and then the suspension I, azone 3g, propylene glycol 3g, and ethylparaben 0.03g were added successively, stirred evenly, coated by a coating machine while hot, cut, and packaged to obtain 10 pieces Babu ointment, its usage and dosage are 1 stick each time, 3 times a day, apply on the temples, one month is a course of treatment, a total of 3 courses of treatment.
三、疗效评价标准3. Efficacy Evaluation Criteria
痊愈:头痛消失,伴随症状转阴,理化检查正常,6个月内未发作。有效:头痛减轻,发作时间缩短或周期延长,有伴随症状或有复发,理化检查正常。无效:头痛及伴随症状等无明显变化。Recovery from illness: the headache disappeared, accompanied by symptoms turning negative, physical and chemical examinations were normal, and there was no outbreak within 6 months. Effective: relieved headache, shortened attack time or prolonged period, accompanied by symptoms or recurrence, normal physical and chemical examination. Ineffective: No obvious changes in headache and accompanying symptoms.
所收治的30例病例中,经3个月治疗,其中治愈21例,有效6例,无效3例,总有效率达90%。结果表明,本发明的中药组合物对治疗偏头痛患者有极其显著的效果。Among the 30 cases treated, after 3 months of treatment, 21 cases were cured, 6 cases were effective, and 3 cases were ineffective. The total effective rate reached 90%. The results show that the traditional Chinese medicine composition of the present invention has extremely significant effect on treating migraine patients.
四.典型病例4. Typical cases
1、李XX,女,46岁,偏头痛病程为1年,每月平均发作次数在2次,每次发作持续时间2天。查:舌质暗红,苔薄白,脉弦紧。使用本发明巴布膏剂,连续使用1个月,诸症消失痊愈,随访半年再未复发。1. Li XX, female, 46 years old, the course of migraine is 1 year, the average number of attacks per month is 2 times, and the duration of each attack is 2 days. Look into: body of the tongue is dark red, fur is thin and white, stringy and tight pulse. Use cataplasm ointment of the present invention, use continuously 1 month, all diseases disappear and recover from illness, follow up a case by regular visits to and do not recur again in half a year.
2、王XX,男42岁,偏头痛病程为3年,每月平均发作次数在3次,每次发作持续时间3天。查:舌质暗红,苔薄白,脉沉迟。使用本发明巴布膏剂,连续使用2个月,诸症消失痊愈,随访半年再未复发。2. Wang XX, male 42 years old, the course of migraine is 3 years, the average number of attacks per month is 3 times, and the duration of each attack is 3 days. Look into: body of the tongue is dark red, fur is thin and white, deep and slow pulse. Use cataplasm ointment of the present invention, use continuously for 2 months, all diseases disappear and recover from illness, follow up a case by regular visits to and do not recur again half a year.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210248282 CN102727834B (en) | 2012-07-18 | 2012-07-18 | Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210248282 CN102727834B (en) | 2012-07-18 | 2012-07-18 | Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102727834A CN102727834A (en) | 2012-10-17 |
CN102727834B true CN102727834B (en) | 2013-09-04 |
Family
ID=46984598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210248282 Expired - Fee Related CN102727834B (en) | 2012-07-18 | 2012-07-18 | Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102727834B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906329A (en) * | 2015-07-09 | 2015-09-16 | 青岛华仁技术孵化器有限公司 | Traditional Chinese medicine combination for oral ulcer treatment and production method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169292A (en) * | 1996-06-21 | 1998-01-07 | 刘庆海 | Preparation of traditional Chinese herbs for treatment of cephalagra |
CN1270043A (en) * | 2000-01-27 | 2000-10-18 | 冀承环 | Medicine for treating hemicrania |
CN101049367A (en) * | 2006-04-07 | 2007-10-10 | 广东宏远集团药业有限公司 | A traditional Chinese medicine for treating migraine |
CN101147781A (en) * | 2006-09-19 | 2008-03-26 | 于振鹏 | Externally-applied medicine for treating migraine pain |
CN101601852A (en) * | 2008-06-13 | 2009-12-16 | 北京中泰天和科技有限公司 | A kind of Chinese medicine preparation for the treatment of vascular migraine |
CN102048963A (en) * | 2009-10-28 | 2011-05-11 | 刘庆华 | TCM prescription for treating migraine |
-
2012
- 2012-07-18 CN CN 201210248282 patent/CN102727834B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169292A (en) * | 1996-06-21 | 1998-01-07 | 刘庆海 | Preparation of traditional Chinese herbs for treatment of cephalagra |
CN1270043A (en) * | 2000-01-27 | 2000-10-18 | 冀承环 | Medicine for treating hemicrania |
CN101049367A (en) * | 2006-04-07 | 2007-10-10 | 广东宏远集团药业有限公司 | A traditional Chinese medicine for treating migraine |
CN101147781A (en) * | 2006-09-19 | 2008-03-26 | 于振鹏 | Externally-applied medicine for treating migraine pain |
CN101601852A (en) * | 2008-06-13 | 2009-12-16 | 北京中泰天和科技有限公司 | A kind of Chinese medicine preparation for the treatment of vascular migraine |
CN102048963A (en) * | 2009-10-28 | 2011-05-11 | 刘庆华 | TCM prescription for treating migraine |
Non-Patent Citations (3)
Title |
---|
王胜春邓.莪术当归延胡索及配伍后的活血行气作用.《解放军药学学报》.2004,第20卷(第5期),第331-334页. |
王非.复方莪红胶囊治疗偏头痛的临床及实验研究.《中国优秀硕博士学位论文全文数据库(硕士) 医药卫生科技辑》.2006,(第11期),全文. * |
莪术当归延胡索及配伍后的活血行气作用;王胜春邓;《解放军药学学报》;20041231;第20卷(第5期);第331-334页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102727834A (en) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102973610A (en) | Method for preparing phthisic adjuvant with extractum of Periplaneta americana | |
CN101152223B (en) | Application of poplar leaf phenolic extract in the preparation of medicine for treating arrhythmia | |
CN102727834B (en) | Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof | |
CN106860509B (en) | Production process of carpet bugle capsule | |
CN103142983B (en) | Medicament for treating chronic pharyngitis | |
CN106727893A (en) | Pharmaceutical composition for radiation stomatitis and preparation method thereof | |
CN102166296B (en) | Medicine for treating bronchitis and asthma and preparation method thereof | |
CN100457167C (en) | Externally used traditional Chinese medicine preparation for treating nasal mucosa erosion and nosebleed and its preparation method | |
CN1256959C (en) | Rhinitis treating medicinal cream | |
CN1261128C (en) | Medicine for treating burn and scald, preparing method thereof | |
CN103705618B (en) | Treat beriberic medicine | |
CN112206279B (en) | Traditional Chinese medicine composition for treating ventricular arrhythmia and preparation method and application thereof | |
CN103006868B (en) | A kind of traditional Chinese medicine composition for treating Behcet's disease | |
CN103211864B (en) | Melastoma dodecandrum Lour extract product and application of Melastoma dodecandrum Lour in preparation of medicines for treating AIDS | |
CN108236623B (en) | Pharmaceutical composition, traditional Chinese medicine oral liquid, traditional Chinese medicine granules and preparation method and application thereof | |
CN101391045B (en) | Traditional Chinese medicine compound preparation for treating migraine and general headache and preparation method thereof | |
CN108143944A (en) | A kind of Chinese medicine composition for treating cold | |
CN104367885A (en) | Traditional Chinese medicine composition for treating facial flat wart and preparation method of traditional Chinese medicine composition | |
CN104352567A (en) | Traditional Chinese medicine for treating thyroid enlargement | |
CN104435938B (en) | Treat pharmaceutical composition and its application of eczema | |
CN102824605B (en) | A kind of Chinese medicine for the treatment of gastric cancer | |
CN103893303B (en) | External traditional Chinese medicine lotion for treating onychomycosis | |
CN119679859A (en) | A kind of Kuzhixiaozhi ointment and preparation method thereof | |
CN103182066A (en) | Medicament for treating canker sores | |
CN103585374A (en) | Unguent for treating onychomycosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130904 Termination date: 20150718 |
|
EXPY | Termination of patent right or utility model |